Cargando…
Tissue metabolite of type I collagen, C1M, and CRP predicts structural progression of rheumatoid arthritis
BACKGROUND: Biomarkers of rheumatoid arthritis (RA) disease activity typically measure inflammation or autoimmunity (e.g. CRP, RF). C1M and C3M, metabolites of type I and III collagen, are markers reflecting tissue metabolism. These markers have been documented to provide additional prognostic and p...
Autores principales: | Bay-Jensen, Anne C., Platt, Adam, Jenkins, Martin A., Weinblatt, Michael E., Byrjalsen, Inger, Musa, Kishwar, Genovese, Mark C., Karsdal, Morten A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390574/ https://www.ncbi.nlm.nih.gov/pubmed/30886991 http://dx.doi.org/10.1186/s41927-019-0052-0 |
Ejemplares similares
-
Translational Biomarkers and Ex Vivo Models of Joint Tissues as a Tool for Drug Development in Rheumatoid Arthritis
por: Kjelgaard‐Petersen, Cecilie F., et al.
Publicado: (2018) -
Serological identification of fast progressors of structural damage with rheumatoid arthritis
por: Siebuhr, Anne Sofie, et al.
Publicado: (2013) -
Circulating Protein Fragments of Cartilage and Connective Tissue Degradation Are Diagnostic and Prognostic Markers of Rheumatoid Arthritis and Ankylosing Spondylitis
por: Bay-Jensen, Anne C., et al.
Publicado: (2013) -
Serological Biomarkers of Joint Tissue Turnover Predict Tocilizumab Response at Baseline
por: Bay-Jensen, Anne C., et al.
Publicado: (2014) -
Early changes in blood-based joint tissue destruction biomarkers are predictive of response to tocilizumab in the LITHE study
por: Bay-Jensen, Anne C., et al.
Publicado: (2016)